evolcSign inStart free
Menu

Tiziana Life Sciences

Clinical-stage biotech developing intranasal and fully human antibody immunotherapies for multiple sclerosis, Alzheimer's and ALS

London, United KingdomFounded 1998tizianalifesciences.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Tiziana Life Sciences

Tiziana Life Sciences is a clinical-stage biotechnology company developing immunotherapies for neurodegenerative and neuroinflammatory diseases. Its lead candidate, Foralumab (TZLS-401), is a fully human anti-CD3 monoclonal antibody being developed for intranasal administration. The pipeline also includes an anti-IL-6 receptor antibody (TZLS-501) and milciclib.

The company targets non-active secondary progressive multiple sclerosis, Alzheimer's disease, ALS, multiple system atrophy and other indications. It uses a lean, virtual research and development model, relying on outside expert teams for each business function. Its clinical trials and expanded access programmes are its main activity.

Tiziana was founded in 1998 and is headquartered in London. It is listed on NASDAQ under the ticker TLSA. Recent updates include a Phase 2 trial of intranasal Foralumab in mild Alzheimer's disease and an orphan drug designation filing with the FDA for Foralumab in multiple system atrophy.

Product: Foralumab (TZLS-401), a fully human anti-CD3 monoclonal antibody for intranasal use in neurodegenerative and neuroinflammatory diseases; also anti-IL-6R mAb TZLS-501 and milciclib.

Jobs at Tiziana Life Sciences

No open positions listed right now.

Leadership

  • Ivor Elrifi · Chief Executive Officer & Executive Director
    Source: company website
  • Keeren Shah · Chief Operating Officer & Chief Financial Officer
    Source: company website

More biotech & pharma companies

  • Torrent Pharma (UK)

    Distributes generic prescription medicines to UK pharmacies, wholesalers and hospitals
    Crawley, United KingdomBiotech & pharmaFounded 20101 open job
    New on EvolcRemote-friendly

  • Tozaro

    Synthetic Smart Polymer affinity ligands for purifying viral vectors and biologics, for cell and gene therapy manufacturers
    Sharnbrook, United KingdomBiotech & pharmaFounded 2015
    New on Evolc

  • Treos Bio

    Develops peptide-based cancer immunotherapies for patients and pharmaceutical development partners
    London, United KingdomBiotech & pharmaFounded 2016
    New on Evolc

  • Trimtech Therapeutics

    Develops small-molecule protein degraders for Alzheimer's, Parkinson's and other neurodegenerative and inflammatory diseases
    Cambridge, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc

  • TTP

    Robotic manufacturing automation for cell therapy developers and manufacturers
    Melbourn, United KingdomBiotech & pharmaFounded 202245 open jobs
    Young company

  • Veramed

    Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsors
    Twickenham, United KingdomBiotech & pharmaFounded 201015 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Google Universal Analytics
  • LiteSpeed
  • WooCommerce
  • WordPress
  • jQuery